430 related articles for article (PubMed ID: 11398915)
1. Perindopril: an updated review of its use in hypertension.
Hurst M; Jarvis B
Drugs; 2001; 61(6):867-96. PubMed ID: 11398915
[TBL] [Abstract][Full Text] [Related]
2. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.
Pannier BM; Guerin AP; Marchais SJ; London GM
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1074-7. PubMed ID: 11903319
[TBL] [Abstract][Full Text] [Related]
3. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of perindopril in the treatment of systemic hypertension.
Oparil S
Am J Cardiol; 2001 Oct; 88(7A):3i-12i. PubMed ID: 11591355
[TBL] [Abstract][Full Text] [Related]
5. [Optimization of BP Control and Arterial Elasticity With Fixed Combination Therapy Perindopril and Amlodipine In Patients With Arterial Hypertension and Increased Pulse Wave Velocity].
Nedogoda SV; Konradi AO; Zvartau NE; Chumachek EV; Ledyaeva AA; Tsoma VV; Salasyuk AS; Judina JS; Smirnova VO; Khripaeva VJ; Palashkin RV
Kardiologiia; 2017 Mar; 57(3):31-38. PubMed ID: 28762933
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
[TBL] [Abstract][Full Text] [Related]
7. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
[TBL] [Abstract][Full Text] [Related]
8. Dosage considerations with perindopril for systemic hypertension.
Sica DA
Am J Cardiol; 2001 Oct; 88(7A):13i-18i. PubMed ID: 11591356
[TBL] [Abstract][Full Text] [Related]
9. Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril.
Alcocer L; Campos C; Bahena JH; Nacaud A; Parra Carillo J; Calvo C; Weber C; Lerebours G; Mickalonis L; Villahermosa MT
Cardiovasc Drugs Ther; 1995 Jun; 9(3):431-6. PubMed ID: 8527353
[TBL] [Abstract][Full Text] [Related]
10. Perindopril treatment for congestive heart failure.
Sonnenblick EH
Am J Cardiol; 2001 Oct; 88(7A):19i-27i. PubMed ID: 11591357
[TBL] [Abstract][Full Text] [Related]
11. Perindopril 2mg/indapamide 0.625mg. Fixed low-dose combination.
McClellan KJ; Markham A
Drugs; 1999 Aug; 58(2):297-302; discussion 303-4. PubMed ID: 10473021
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
[TBL] [Abstract][Full Text] [Related]
13. First-line treatment in hypertension. Role of perindopril.
Zanchetti A
Drugs; 1990; 39 Suppl 1():71-5. PubMed ID: 2407495
[TBL] [Abstract][Full Text] [Related]
14. Perindopril: a review of its use in patients with or at risk of developing coronary artery disease.
Curran MP; McCormack PL; Simpson D
Drugs; 2006; 66(2):235-55. PubMed ID: 16451098
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy.
Asmar R; Garcia-Puig J; Gosse P; Karpov YA; De Leeuws PW; Magometschniggs D; Matos L; Schmieder R
Vasc Health Risk Manag; 2007; 3(4):371-80. PubMed ID: 17969366
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
Ruilope LM; Schaefer A
Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
[TBL] [Abstract][Full Text] [Related]
17. Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study.
Ogilvie RI; Anand S; Roy P; De Souza S;
Clin Drug Investig; 2008; 28(11):673-86. PubMed ID: 18840010
[TBL] [Abstract][Full Text] [Related]
18. Perindopril: in congestive heart failure.
Simpson D; Noble S; Goa KL
Drugs; 2002; 62(9):1367-77; discussion 1378-9. PubMed ID: 12076191
[TBL] [Abstract][Full Text] [Related]
19. [Effect of twelve-month combined therapy with perindopril and indapamide on the level of blood pressure and left ventricular hypertrophy in patients with hypertensive disease].
Timofeeva LA; Alekhin MN; Ugriumov MO; Chumakova OS; Larina VN; Sidorenko BA
Kardiologiia; 2006; 46(3):30-4. PubMed ID: 16710252
[TBL] [Abstract][Full Text] [Related]
20. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension.
Anan F; Takahashi N; Ooie T; Yufu K; Hara M; Nakagawa M; Yonemochi H; Saikawa T; Yoshimatsu H
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):353-9. PubMed ID: 15918057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
